These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

356 related items for PubMed ID: 23862168

  • 1. HFE mutations in Caucasian participants of the Hemochromatosis and Iron Overload Screening study with serum ferritin level <1000 µg/L.
    Adams PC, McLaren CE, Speechley M, McLaren GD, Barton JC, Eckfeldt JH.
    Can J Gastroenterol; 2013 Jul; 27(7):390-2. PubMed ID: 23862168
    [Abstract] [Full Text] [Related]

  • 2. Hemochromatosis and iron-overload screening in a racially diverse population.
    Adams PC, Reboussin DM, Barton JC, McLaren CE, Eckfeldt JH, McLaren GD, Dawkins FW, Acton RT, Harris EL, Gordeuk VR, Leiendecker-Foster C, Speechley M, Snively BM, Holup JL, Thomson E, Sholinsky P, Hemochromatosis and Iron Overload Screening (HEIRS) Study Research Investigators.
    N Engl J Med; 2005 Apr 28; 352(17):1769-78. PubMed ID: 15858186
    [Abstract] [Full Text] [Related]

  • 3. Predicting C282Y homozygote genotype for hemochromatosis using serum ferritin and transferrin saturation values from 44,809 participants of the HEIRS study.
    Lim A, Speechley M, Adams PC.
    Can J Gastroenterol Hepatol; 2014 Oct 28; 28(9):502-4. PubMed ID: 25314357
    [Abstract] [Full Text] [Related]

  • 4. HFE C282Y homozygosity is associated with lower total and low-density lipoprotein cholesterol: The hemochromatosis and iron overload screening study.
    Adams PC, Pankow JS, Barton JC, Acton RT, Leiendecker-Foster C, McLaren GD, Speechley M, Eckfeldt JH.
    Circ Cardiovasc Genet; 2009 Feb 28; 2(1):34-7. PubMed ID: 20031565
    [Abstract] [Full Text] [Related]

  • 5. Relationships of serum ferritin, transferrin saturation, and HFE mutations and self-reported diabetes in the Hemochromatosis and Iron Overload Screening (HEIRS) study.
    Acton RT, Barton JC, Passmore LV, Adams PC, Speechley MR, Dawkins FW, Sholinsky P, Reboussin DM, McLaren GD, Harris EL, Bent TC, Vogt TM, Castro O.
    Diabetes Care; 2006 Sep 28; 29(9):2084-9. PubMed ID: 16936157
    [Abstract] [Full Text] [Related]

  • 6. Determinants and characteristics of mean corpuscular volume and hemoglobin concentration in white HFE C282Y homozygotes in the hemochromatosis and iron overload screening study.
    McLaren CE, Barton JC, Gordeuk VR, Wu L, Adams PC, Reboussin DM, Speechley M, Chang H, Acton RT, Harris EL, Ruggiero AM, Castro O, Hemochromatosis and Iron Overload Screening Study Research Investigators.
    Am J Hematol; 2007 Oct 28; 82(10):898-905. PubMed ID: 17597476
    [Abstract] [Full Text] [Related]

  • 7. HFE C282Y homozygotes aged 25-29 years at HEIRS Study initial screening.
    Barton JC, Acton RT, Leiendecker-Foster C, Lovato L, Adams PC, McLaren GD, Eckfeldt JH, McLaren CE, Reboussin DM, Gordeuk VR, Speechley MR, Reiss JA, Press RD, Dawkins FW, Hemochromatosis and Iron Overload Screening (HEIRS) Study Research Investigators.
    Genet Test; 2007 Oct 28; 11(3):269-75. PubMed ID: 17949288
    [Abstract] [Full Text] [Related]

  • 8. Initial screening transferrin saturation values, serum ferritin concentrations, and HFE genotypes in whites and blacks in the Hemochromatosis and Iron Overload Screening Study.
    Barton JC, Acton RT, Dawkins FW, Adams PC, Lovato L, Leiendecker-Foster C, McLaren CE, Reboussin DM, Speechley MR, Gordeuk VR, McLaren GD, Sholinsky P, Harris EL.
    Genet Test; 2005 Oct 28; 9(3):231-41. PubMed ID: 16225403
    [Abstract] [Full Text] [Related]

  • 9. Probability of C282Y homozygosity decreases as liver transaminase activities increase in participants with hyperferritinemia in the hemochromatosis and iron overload screening study.
    Adams PC, Speechley M, Barton JC, McLaren CE, McLaren GD, Eckfeldt JH.
    Hepatology; 2012 Jun 28; 55(6):1722-6. PubMed ID: 22183642
    [Abstract] [Full Text] [Related]

  • 10. Initial screening transferrin saturation values, serum ferritin concentrations, and HFE genotypes in Native Americans and whites in the Hemochromatosis and Iron Overload Screening Study.
    Barton JC, Acton RT, Lovato L, Speechley MR, McLaren CE, Harris EL, Reboussin DM, Adams PC, Dawkins FW, Gordeuk VR, Walker AP, Hemochromatosis and Iron Overload Screening Study Research Investigators.
    Clin Genet; 2006 Jan 28; 69(1):48-57. PubMed ID: 16451136
    [Abstract] [Full Text] [Related]

  • 11. Epidemiology and diagnostic testing for hemochromatosis and iron overload.
    Adams PC.
    Int J Lab Hematol; 2015 May 28; 37 Suppl 1():25-30. PubMed ID: 25976957
    [Abstract] [Full Text] [Related]

  • 12. Significance of H63D homozygosity in a Basque population with hemochromatosis.
    Castiella A, Zapata E, de Juan MD, Otazua P, Fernandez J, Zubiaurre L, Arriola JA, Gipuzkoa Hemochromatosis Group.
    J Gastroenterol Hepatol; 2010 Jul 28; 25(7):1295-8. PubMed ID: 20594259
    [Abstract] [Full Text] [Related]

  • 13. Iron-overload and genotypic expression of HFE mutations H63D/C282Y and transferrin receptor Hin6I and BanI polymorphism in german patients with hereditary haemochromatosis.
    Gottschalk R, Seidl C, Schilling S, Braner A, Seifried E, Hoelzer D, Kaltwasser JP.
    Eur J Immunogenet; 2000 Jun 28; 27(3):129-34. PubMed ID: 10940080
    [Abstract] [Full Text] [Related]

  • 14. Correlation between iron status and genetic hemochromatosis (codon C282Y) in a large German population.
    Wrede CE, Hutzler S, Bollheimer LC, Buettner R, Hellerbrand C, Schöelmerich J, Palitzsch KD.
    Isr Med Assoc J; 2004 Jan 28; 6(1):30-3. PubMed ID: 14740507
    [Abstract] [Full Text] [Related]

  • 15. A population-based study of the biochemical and clinical expression of the H63D hemochromatosis mutation.
    Gochee PA, Powell LW, Cullen DJ, Du Sart D, Rossi E, Olynyk JK.
    Gastroenterology; 2002 Mar 28; 122(3):646-51. PubMed ID: 11874997
    [Abstract] [Full Text] [Related]

  • 16. Hemochromatosis mutations in the general population: iron overload progression rate.
    Andersen RV, Tybjaerg-Hansen A, Appleyard M, Birgens H, Nordestgaard BG.
    Blood; 2004 Apr 15; 103(8):2914-9. PubMed ID: 15070663
    [Abstract] [Full Text] [Related]

  • 17. HFE Cys282Tyr homozygotes with serum ferritin concentrations below 1000 microg/L are at low risk of hemochromatosis.
    Allen KJ, Bertalli NA, Osborne NJ, Constantine CC, Delatycki MB, Nisselle AE, Nicoll AJ, Gertig DM, McLaren CE, Giles GG, Hopper JL, Anderson GJ, Olynyk JK, Powell LW, Gurrin LC, HealthIron Study Investigators.
    Hepatology; 2010 Sep 15; 52(3):925-33. PubMed ID: 20583211
    [Abstract] [Full Text] [Related]

  • 18. Heritability of serum iron measures in the hemochromatosis and iron overload screening (HEIRS) family study.
    McLaren CE, Barton JC, Eckfeldt JH, McLaren GD, Acton RT, Adams PC, Henkin LF, Gordeuk VR, Vulpe CD, Harris EL, Harrison BW, Reiss JA, Snively BM.
    Am J Hematol; 2010 Feb 15; 85(2):101-5. PubMed ID: 20095037
    [Abstract] [Full Text] [Related]

  • 19. [Molecular genetic diagnostics and screening of hereditary hemochromatosis].
    Zlocha J, Kovács L, Pozgayová S, Kupcová V, Durínová S.
    Vnitr Lek; 2006 Jun 15; 52(6):602-8. PubMed ID: 16871764
    [Abstract] [Full Text] [Related]

  • 20. Biological variability of transferrin saturation and unsaturated iron-binding capacity.
    Adams PC, Reboussin DM, Press RD, Barton JC, Acton RT, Moses GC, Leiendecker-Foster C, McLaren GD, Dawkins FW, Gordeuk VR, Lovato L, Eckfeldt JH.
    Am J Med; 2007 Nov 15; 120(11):999.e1-7. PubMed ID: 17976429
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.